Format
Sort by

Send to

Choose Destination

Links from Books

Items: 5

1.

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks.

García-Borreguero D, Högl B, Ferini-Strambi L, Winkelman J, Hill-Zabala C, Asgharian A, Allen R.

Mov Disord. 2012 Feb;27(2):277-83. doi: 10.1002/mds.24889. Epub 2012 Jan 4.

PMID:
22328464
2.

Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).

Tzonova D, Larrosa O, Calvo E, Granizo JJ, Williams AM, de la Llave Y, García-Borreguero D.

Sleep Med. 2012 Feb;13(2):151-5. doi: 10.1016/j.sleep.2011.09.015. Epub 2012 Jan 26.

PMID:
22281003
3.

Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.

Pullen SJ, Wall CA, Angstman ER, Munitz GE, Kotagal S.

J Clin Sleep Med. 2011 Dec 15;7(6):587-96. doi: 10.5664/jcsm.1456.

4.

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.

Ma JF, Wan Q, Hu XY, Sun SG, Wang WZ, Zhao ZX, Wang YJ, Liu CF, Li JM, Jiang YP, Chen SD.

Sleep Med. 2012 Jan;13(1):58-63. doi: 10.1016/j.sleep.2011.03.021. Epub 2011 Dec 3.

PMID:
22137119
5.

Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.

Inoue Y, Uchimura N, Kuroda K, Hirata K, Hattori N.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):251-7. doi: 10.1016/j.pnpbp.2011.10.009. Epub 2011 Oct 19.

PMID:
22036917

Supplemental Content

Write to the Help Desk